[Main results of research reported by the Center's Department of Innovation in Radiotherapy].
The efficacy of multimodality conservative treatment for prostate and bladder cancer and cervical carcinoma was improved due to integration of such modem modalities as intra-arterial chemotherapy, local hyperthermia and hyperglycemia and combination of local and systemic radiomodifiers. Our methods use criteria of actual survival and are intended to raise it.
Zharinov
G M
GM
Neklasova
N Iu
NIu
Metelev
V V
VV
Agafonova
M V
MV
Rumiantseva
S Iu
SIu
Volodina
L  A
L
Malysheva
L G
LG
Gosteva
S N
SN
Zaikin
G V
GV
Gasparian
N A
NA
Mironovskaia
N V
NV
Demidov
D A
DA
Samsonova
V I
VI
Bagdasarian
N S
NS
D000047:Academies and Institutes; D000818:Animals; D035843:Biomedical Research; D005260:Female; D006077:Government Agencies; D006801:Humans; D028022:Low-Level Light Therapy; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D011878:Radiotherapy / Q000379:methods / Q000639:trends; D013964:Thyroid Neoplasms / Q000532:radiotherapy; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy
D011838:Radiation-Sensitizing Agents